SCHEMBL29910532

SCHEMBL29910532

Nc1nnc(Cl)cc1N1CC2CCC(C1)N2c1cccc(CN2CCN(C(=O)OCc3ccccc3)CC2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 1/20 0.43
▸ CHRM4 P08173 4/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ TMEM97 Q5BJF2 1/20 0.40
▸ SIGMAR1 Q99720 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ FNTA P49354 2/20 0.38
▸ FNTB P49356 2/20 0.38
▸ PGGT1B P53609 2/20 0.38
▸ HTR1A P08908 1/20 0.38
▸ HTR7 P34969 1/20 0.38
▸ SMARCA2 P51531 2/20 0.38
▸ SMARCA4 P51532 2/20 0.38
▸ FAAH O00519 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30796426 1.00 OPRM1 (0.43) OPRM1CHRM4SMN1; SMN2CYP2C19TMEM97
SCHEMBL23301307 1.00 OPRM1 (0.43) OPRM1CHRM4SMN1; SMN2CYP2C19TMEM97
SCHEMBL29942615 0.91 CHRM4 (0.42) OPRM1CHRM4SMN1; SMN2CYP2C19TMEM97
SCHEMBL29910593 0.89 SMARCA2 (0.46) OPRM1CHRM4SMN1; SMN2CYP2C19TMEM97
SCHEMBL23301401 0.89 SMARCA2 (0.46) OPRM1CHRM4SMN1; SMN2CYP2C19TMEM97
SCHEMBL23301408 0.89 TMEM97 (0.39) OPRM1CHRM4SMN1; SMN2CYP2C19TMEM97
SCHEMBL29910559 0.89 TMEM97 (0.39) OPRM1CHRM4SMN1; SMN2CYP2C19TMEM97
SCHEMBL23301459 0.89 SMARCA2 (0.53) OPRM1SMARCA2SMARCA4
SCHEMBL30797027 0.89 SMARCA2 (0.53) OPRM1SMARCA2SMARCA4
SCHEMBL29943157 0.89 SMARCA2 (0.53) OPRM1SMARCA2SMARCA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4054724-A1 BIFUNCTIONAL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2022-09-14 — — EP disclosed
EP-4051674-A1 BIFUNCTIONAL COMPOUNDS FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2022-09-07 — — EP disclosed
Send feedback